title: The application of the Accelerated Stability Assessment Program (ASAP) to quality by design (QbD) for drug product stability.
abstract: An isoconversion paradigm, where times in different temperature and humidity-controlled stability chambers are set to provide a fixed degradant level, is shown to compensate for the complex, non-single order kinetics of solid drug products. A humidity-corrected Arrhenius equation provides reliable estimates for temperature and relative humidity effects on degradation rates. A statistical protocol is employed to determine best fits for chemical stability data, which in turn allows for accurate estimations of shelf life (with appropriate confidence intervals) at any storage condition including inside packaging (based on the moisture vapor transmission rate of the packaging and moisture sorption isotherms of the internal components). These methodologies provide both faster results and far better predictions of chemical stability limited shelf life (expiry) than previously possible. Precise shelf-life estimations are generally determined using a 2-week, product-specific protocol. Once the model for a product is developed, it can play a critical role in providing the product understanding necessary for a quality by design (QbD) filing for product approval and enable rational control strategies to assure product stability. Moreover, this Accelerated Stability Assessment Program (ASAP) enables the coupling of product attributes (e.g., moisture content, packaging options) to allow for flexibility in how control strategies are implemented to provide a balance of cost, speed, and other factors while maintaining adequate stability.
authors: Pfizer Inc., Groton, Connecticut 06340, USA. ken.waterman@pfizer.com
authors: Kenneth Craig
authors: KC
authors: Waterman
mesh_terms: D004304:Dosage Forms; D004349:Drug Packaging; D004355:Drug Stability; D004356:Drug Storage; D005079:Excipients; D006813:Humidity; D007700:Kinetics; D008956:Models, Chemical; D015397:Program Evaluation; D012107:Research Design; D013678:Technology, Pharmaceutical / Q000379:methods*; D013696:Temperature
chemical_list: D004304:Dosage Forms; D005079:Excipients